Investment Company Act Rules
 
Rule 3a-8
Certain Research and Development Companies
(a) Notwithstanding sections 3(a)(1)(A) and
3(a)(1)(C) of the Act
(15 U.S.C. 80a-3(a)(1)(A) and 80a-3(a)(1)(C)), an issuer will be deemed
not to be an investment company if:
(1) Its research and development expenses, for the last four
fiscal
quarters combined, are a substantial percentage of its total expense for
the same period;
(2) Its net income derived from investments in securities,
for the
last four fiscal quarters combined, does not exceed twice the amount of
its research and development expenses for the same period;
(3) Its expenses for investment advisory and management
activities,
investment research and custody, for the last four fiscal quarters,
combined, do not exceed five percent of its total expenses for the same
period; (4) Its investments in securities are capital preservation
investments, except that:
(i) No more than 10 percent of the issuer's total assets may
consist
of other investments, or
(ii) No more than 25 percent of the issuer's total assets may
consist of other investments, provided that at least 75 percent of such
other investments are investments made pursuant to a collaborative
research and development arrangement; (5) It does not hold itself out as being engaged in the
business of
investing, reinvesting or trading in securities, and it is not a special
situation investment company;
(6) It is primarily engaged, directly, through majority-owned
subsidiaries, or through companies which it controls primarily, in a
business or businesses other than that of investing, reinvesting,
owning, holding, or trading in securities, as evidenced by:
(i) The activities of its officers, directors and employees;
(ii) Its public representations of policies;
(iii) Its historical development; and
(iv) An appropriate resolution of its board of directors,
which
resolution or action has been recorded contemporaneously in its minute
books or comparable documents; and
(7) Its board of directors has adopted a written investment
policy
with respect to the issuer's capital preservation investments.
(b) For purposes of this section:
(1) All assets shall be valued in accordance with section
2(a)(41)(A) of the Act (15 U.S.C. 80a-2(a)(41)(A));
(2) The percentages described in this section are determined
on an
unconsolidated basis, except that the issuer shall consolidate its
financial statements with the financial statements of any wholly-owned
subsidiaries;
(3) Board of directors means the issuer's board of directors
or an
appropriate person or persons performing similar functions for any
issuer not having a board of directors;
(4) Capital preservation investment means an investment that
is made
to conserve capital and liquidity until the funds are used in the
issuer's primary business or businesses;
(5) Controlled primarily means controlled within the meaning
of
section 2(a)(9) of the Act (15 U.S.C. 80a-2(a)(9)) with a degree of
control that is greater than that of any other person;
(6) Investment made pursuant to a collaborative research and
development arrangement means an investment in an investee made pursuant
to a business relationship which:
(i) Is designed to achieve narrowly focused goals that are
directly
related to, and an integral part of, the issue's research and
development activities;
(ii) Calls for the issuer to conduct joint research and
development
activities with the investee or a company controlled primarily by, or
which controls primarily, the investee; and
(iii) Is not entered into for the purpose of avoiding
regulation
under the Act;
(7) Investments in securities means all securities other than
securities issued by majority-owned subsidiaries and companies
controlled primarily by the issuer that conduct similar types of
businesses, through which the issuer is engaged primarily in a business
other than that of investing, reinvesting, owning, holding, or trading
in securities;
(8) Other investment means an investment in securities that
is not a
capital preservation investment; and
(9) Research and development expenses means research and
development
expenses as defined in FASB Statement of Financial Accounting Standards
No. 2, Accounting for Research and Development Costs, as currently in
effect or as it may be subsequently revised.
Regulatory History |
|
68 FR 37052, June 20, 2003 |
|